Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein
about
HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoterInteractions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged basesTwist and p53 reciprocally regulate target genes via direct interactionPhysical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expressionBorna disease virus phosphoprotein represses p53-mediated transcriptional activity by interference with HMGB1Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotypeHigh Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate CancerHMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequencesCellular processing of platinum anticancer drugsHigh-mobility group box 1 and cancer.Analysis and verification of the HMGB1 signaling pathway.HMGB1: the jack-of-all-trades protein is a master DNA repair mechanic.Unusual DNA binding modes for metal anticancer complexes.HMGB1 in health and disease.HMGB1 Promotes Mitochondrial Dysfunction-Triggered Striatal Neurodegeneration via Autophagy and Apoptosis Activation.Detection of activity centers in cellular pathways using transcript profiling.Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathwayCommitment issues: linking positive selection signals and lineage diversification in the thymus.High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs.HMGB1 silence could promote MCF-7 cell apoptosis and inhibit invasion and metastasis.Life after death: targeting high mobility group box 1 in emergent cancer therapies.Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.Chromatin protein HMGB2 regulates articular cartilage surface maintenance via beta-catenin pathway.Downregulation of vimentin expression increased drug resistance in ovarian cancer cells.H1 and HMGB1: modulators of chromatin structure.Different recognition of DNA modified by aatitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53.Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'-->5' exonuclease activity.Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcriptionBinding of RNA to p53 regulates its oligomerization and DNA-binding activity.A distance difference matrix approach to identifying transcription factors that regulate differential gene expression.Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma.
P2860
Q24292041-F0832EDB-A5D8-4D10-9020-416508C61F96Q24298420-8CF3C205-E8BE-4560-B46C-7FF0A80FAB42Q24316412-67FAA5E8-6F8F-4663-BD41-B36E4966BABAQ24529877-69B56DD7-3247-414C-9B03-812F4F3F9908Q24648308-4FD522BB-53EC-43D4-B91C-11DFAFC3F1F8Q24685044-9C68EE1E-DD6C-4F98-A918-5C8726925010Q26774902-14824AB1-BE0C-43EF-9D7C-165535E2F368Q28211815-ACDD9452-2260-481F-B094-4AEF364A477AQ29617899-91C67371-7431-454F-B118-D9F9BB38B76CQ33638306-18378764-3196-431F-9E9C-59BF33487208Q33755561-5397E8FE-04D0-4C82-AD68-85843B085281Q33799406-0D975234-D000-44BF-8642-F90DF7BB15F0Q34071185-E6E06801-8B10-4719-9B5A-13243722DBF5Q34622835-2E31B56A-0AF2-4D68-9E93-ED949D0210E4Q35840562-71693F46-6A81-4150-9995-FFE52279D233Q35910908-7BDC6C4C-4A90-46B0-8889-0D7A826A20A9Q35913266-F7084FDC-03F4-47CE-B85F-8CD8C8C7CF7FQ36382781-BCAF2FE6-40CE-4B61-A005-FF3DB3B4DAD5Q36396288-333C691C-B7A0-485B-86A6-8983CA6674F4Q36511773-2F227466-4547-490C-99FB-D2AF6E9E3186Q36562901-C8539474-B50E-41E2-BAD2-54B62374A7F6Q37351875-55D1A1D0-4AAB-48EF-99EF-92410A5B07A5Q37377298-A60B053D-52CD-475A-94F2-A60B6FF4EAFCQ37564586-ECAAD0F5-C39D-4E74-A2A1-5AD931513362Q37995719-5211961D-8045-45BA-B7A6-F7C06D761C5BQ38302471-FEBAFA9A-84B4-4E47-9523-7CF43C81CAB3Q38303725-EE20ED1C-5929-4F41-884D-5EC49C76D1C8Q39675422-41E1B888-08B8-43D9-8552-7C9D9A29930EQ39777970-DCA79B7A-93E8-4610-B538-94025BF4601CQ40570060-51E45FDD-7F90-42AB-A2E2-F5566DA62851Q42467310-1ABAD514-0D44-4C93-BEDB-A69B75B7A61AQ52562715-6EB9E49F-FE9C-4882-96FE-793E4C3BBC5B
P2860
Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Interaction with p53 enhances ...... high mobility group 1 protein
@ast
Interaction with p53 enhances ...... high mobility group 1 protein
@en
Interaction with p53 enhances ...... high mobility group 1 protein
@nl
type
label
Interaction with p53 enhances ...... high mobility group 1 protein
@ast
Interaction with p53 enhances ...... high mobility group 1 protein
@en
Interaction with p53 enhances ...... high mobility group 1 protein
@nl
prefLabel
Interaction with p53 enhances ...... high mobility group 1 protein
@ast
Interaction with p53 enhances ...... high mobility group 1 protein
@en
Interaction with p53 enhances ...... high mobility group 1 protein
@nl
P2093
P2860
P3181
P356
P1476
Interaction with p53 enhances ...... high mobility group 1 protein
@en
P2093
G Nagatani
P2860
P304
P3181
P356
10.1074/JBC.M008143200
P407
P577
2001-03-09T00:00:00Z